Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00002832
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Conditions
- Interventions
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00004263
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
- Conditions
- Interventions
- First Posted Date
- 2004-07-23
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 95
- Registration Number
- NCT00088218
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
- Conditions
- Interventions
- First Posted Date
- 2004-07-23
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT00088231
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
- First Posted Date
- 2004-07-22
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT00003677
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
A Phase II Study of CC-5013 in Myelofibrosis
- First Posted Date
- 2004-07-14
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT00087672
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
RAD001 in Recurrent Endometrial Cancer Patients
- First Posted Date
- 2004-07-14
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT00087685
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2022-09-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 474
- Registration Number
- NCT00086762
- Locations
- 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸University of Texas M.D. Anderson CCOP Research Base, Houston, Texas, United States
🇺🇸CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
- First Posted Date
- 2004-07-01
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT00002837
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2004-06-30
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 61
- Registration Number
- NCT00002565
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇧🇷Faculdade de Medicina do ABC, Sao Paulo, Brazil
🇨🇱Clinica Alemana, Santiago, Chile